Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

Acellera Therapeutics, a pioneer in computational chemistry and AI-driven drug discovery, today announced the launch of ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets and develop small molecule ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...

Explore the rise of digital biology, where AI like AlphaFold is transforming protein folding, drug discovery, and scientific ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.